Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Withdrawn 1Terminated 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 1

Conditions

Breast Neoplasms 870Neoplasms 657Prostatic Neoplasms 448Lung Neoplasms 361Colorectal Neoplasms 333Carcinoma, Non-Small-Cell Lung 324Leukemia, Myeloid, Acute 256Pancreatic Neoplasms 222Brain Neoplasms 204Multiple Myeloma 202Neoplasm Metastasis 198Carcinoma, Hepatocellular 182Head and Neck Neoplasms 178Glioblastoma 169Precursor Cell Lymphoblastic Leukemia-Lymphoma 167Melanoma 156Ovarian Neoplasms 151Squamous Cell Carcinoma of Head and Neck 150Rectal Neoplasms 135Recurrence 133Hematologic Neoplasms 127Sarcoma 125Uterine Cervical Neoplasms 124Stomach Neoplasms 118Glioma 117Triple Negative Breast Neoplasms 116Carcinoma, Renal Cell 116Motor Activity 101Urinary Bladder Neoplasms 99Colonic Neoplasms 99

Interventions

Speech Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Communication Disorders × 90 days × Clear all
NCT04969874 2026-05-12

E-CRIL_MAX

University Hospital, Toulouse

Phase NA Withdrawn

Communication Disorders

NCT05189366 2026-04-14

SOPHNEURO

Institut Cancerologie de l'Ouest

Phase NA Terminated
13 enrolled 8 charts
CNS

Communication Disorders, Glioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡